X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (164) 164
index medicus (146) 146
hematology (123) 123
aged (92) 92
oncology (92) 92
male (90) 90
female (89) 89
middle aged (88) 88
multiple myeloma (75) 75
bortezomib (68) 68
adult (64) 64
aged, 80 and over (64) 64
treatment outcome (51) 51
multiple myeloma - drug therapy (50) 50
antineoplastic combined chemotherapy protocols - therapeutic use (44) 44
prognosis (44) 44
survival (41) 41
dexamethasone (36) 36
cancer (35) 35
multiple-myeloma (35) 35
stem-cell transplantation (35) 35
hematology, oncology and palliative medicine (30) 30
lenalidomide (29) 29
thalidomide (29) 29
chemotherapy (26) 26
antineoplastic agents - therapeutic use (25) 25
therapy (23) 23
multiple myeloma - complications (22) 22
survival analysis (21) 21
thalidomide - analogs & derivatives (21) 21
abridged index medicus (20) 20
care and treatment (20) 20
multiple myeloma - mortality (19) 19
antineoplastic combined chemotherapy protocols - adverse effects (18) 18
multiple myeloma - diagnosis (18) 18
rituximab (18) 18
waldenstrom macroglobulinemia - drug therapy (18) 18
consensus panel recommendations (17) 17
multiple myeloma - pathology (17) 17
survival rate (16) 16
combination (15) 15
dexamethasone - administration & dosage (15) 15
monoclonal gammopathy (15) 15
amyloidosis (14) 14
analysis (14) 14
dexamethasone - therapeutic use (14) 14
disease-free survival (14) 14
neoplasm staging (14) 14
patient outcomes (14) 14
retrospective studies (14) 14
2nd international workshop (13) 13
boronic acids - therapeutic use (13) 13
diagnosis (13) 13
expression (13) 13
medical research (13) 13
multivariate analysis (13) 13
pharmacology & pharmacy (13) 13
pyrazines - therapeutic use (13) 13
thalidomide - administration & dosage (13) 13
waldenstrom macroglobulinemia - pathology (13) 13
al amyloidosis (12) 12
biomarkers (12) 12
follow-up studies (12) 12
medical prognosis (12) 12
myeloma (12) 12
risk factors (12) 12
thalidomide - therapeutic use (12) 12
angiogenesis (11) 11
antineoplastic agents - adverse effects (11) 11
boronic acids - administration & dosage (11) 11
carfilzomib (11) 11
disease (11) 11
disease progression (11) 11
drug therapy (11) 11
light-chain amyloidosis (11) 11
medical colleges (11) 11
melphalan (11) 11
multiple myeloma - therapy (11) 11
patients (11) 11
plus dexamethasone (11) 11
pyrazines - administration & dosage (11) 11
refractory multiple-myeloma (11) 11
thalidomide - adverse effects (11) 11
biopsy (10) 10
ibrutinib (10) 10
kaplan-meier estimate (10) 10
multiple myeloma - blood (10) 10
phase-ii (10) 10
recurrence (10) 10
waldenstrom macroglobulinemia - diagnosis (10) 10
waldenstrom macroglobulinemia - therapy (10) 10
zoledronic acid (10) 10
antibodies, monoclonal - therapeutic use (9) 9
article (9) 9
cyclophosphamide - administration & dosage (9) 9
immunoglobulin light chains - blood (9) 9
immunoglobulin light-chain amyloidosis (9) 9
immunoglobulins (9) 9
immunologic factors - therapeutic use (9) 9
low-dose dexamethasone (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC medical genetics, ISSN 1471-2350, 01/2019, Volume 20, Issue 1, pp. 23 - 5
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1894 - 1894
A deep and rapid hematologic response is fundamental in order to improve the outcomes (overall survival (OS) and organ responses) of patients with AL... 
Journal Article
Leukemia, ISSN 0887-6924, 2019, Volume 33, Issue 11, pp. 2654 - 2661
A staging system was developed a decade ago for patients with Waldenström’s macroglobulinemia (WM), however, since then WM treatments have changed. A revised... 
Medical prognosis | Rituximab | Risk | Serum albumin | Patients | b2-microglobulin | Macroglobulinemia
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 11/2019, p. 101929
Journal Article
Medicine, ISSN 0025-7974, 11/2019, Volume 98, Issue 44, p. e17794
Byline: Maria Gavriatopoulou, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General... 
Journal Article
Blood Advances, ISSN 2473-9529, 10/2019, Volume 3, Issue 20, pp. 3002 - 3009
Key Points Bortezomib with dexamethasone and low-dose lenalidomide is an active therapy for previously untreated patients with AL amyloidosis. VRD can induce... 
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. e121 - e122
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. e318 - e319
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. e28 - e29
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. e327 - e327
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.